NPI: 1801149950 · HIALEAH, FL 33016 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/25/2012
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 10/25/2012 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 21,634 | $2.15M |
| 2019 | 38,725 | $3.22M |
| 2020 | 33,237 | $3.58M |
| 2021 | 21,055 | $697K |
| 2022 | 9,870 | $1.15M |
| 2023 | 2,533 | $56K |
| 2024 | 570 | $28K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 42,547 | 1,452 | $3.50M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 34,649 | 2,010 | $3.15M |
| J1270 | Injection, doxercalciferol, 1 mcg | 22,808 | 1,220 | $1.64M |
| A4657 | Syringe, with or without needle, each | 4,639 | 1,625 | $831K |
| J1756 | Injection, iron sucrose, 1 mg | 8,991 | 1,327 | $718K |
| 85041 | 2,256 | 1,207 | $172K | |
| 85048 | 2,256 | 1,207 | $172K | |
| 83970 | 1,567 | 865 | $127K | |
| 83540 | 1,539 | 862 | $126K | |
| 82746 | 1,745 | 966 | $123K | |
| 83550 | 1,521 | 850 | $121K | |
| 82728 | 1,309 | 747 | $102K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 933 | 390 | $59K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 208 | 107 | $16K |
| 82108 | 163 | 98 | $12K | |
| 82607 | 156 | 89 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 133 | 77 | $6K |
| 85045 | 114 | 59 | $4K | |
| 90662 | 40 | 25 | $4K | |
| G0008 | Administration of influenza virus vaccine | 50 | 32 | $3K |